Search clinical trials for: Empagliflozin high
Total 7207 results
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Doris...RecruitingType2 Diabetes | Heart Failure With Preserved Ejection FractionUnited States
-
Chong Kun Dang PharmaceuticalUnknownDiabetes Mellitus, Type IIKorea, Republic of
-
Yale UniversityBoehringer IngelheimRecruitingEnd Stage Renal Disease on DialysisUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, Croatia, Czech Republic, Denmark, Estonia, France, Georgia, Greece, Hong Kong, Hungary, India, Indonesia, Israel, Italy, Japan, Korea, Republic of, Malaysia and more
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusCzechia, Hungary, United States, Mexico, Germany, Austria, Israel, Puerto Rico, Spain
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Loyola UniversityCompletedObesity | Shoulder ImpingementUnited States
-
EMSNot yet recruiting
-
Genuine Research Center, EgyptHikma PharmaCompleted
-
Loyola UniversityCompletedObese | Beach Chair Position | Shoulder Arthoscopy | Cerebral Desaturation EventsUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Denmark, France, Ireland, Korea, Republic of, Portugal, United Kingdom
-
AstraZenecaRecruitingHeart Failure and Impaired Kidney FunctionSpain, France, Germany, Italy, United States, Argentina, Czechia, Vietnam, Peru, China, Philippines, Saudi Arabia, Australia, Austria, Canada, Japan, Malaysia, Poland, Taiwan, Thailand, Israel, Brazil, Finland, Greece, Mexico, United Kingdom and more
-
University of VirginiaNational Heart, Lung, and Blood Institute (NHLBI)RecruitingType2 Diabetes | Insulin SensitivityUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Denmark, Canada, Belgium, China, Italy, Germany, Spain, Netherlands, Hungary, Japan, Norway, Poland, Sweden, Czechia
-
Kobe UniversityBoehringer IngelheimActive, not recruitingInsulin Resistance - Type A | Insulin Resistance - Type B | Lipoatrophic Diabetes Mellitus | Insulin Resistance SyndromeJapan
-
AstraZenecaRecruitingLiver CirrhosisDenmark, Spain, Germany, United States, France, Australia, China, Netherlands, Belgium, Switzerland, Austria, United Kingdom, Taiwan, Canada, Czechia
-
Ananda Basu, MDNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); DexCom... and other collaboratorsCompletedType 1 DiabetesUnited States
-
Instituto Nacional de Cardiologia Ignacio ChavezNot yet recruitingSTEMI | No-Reflow Phenomenon
-
China National Center for Cardiovascular DiseasesRecruitingHypertrophic Cardiomyopathy | Heart Failure With Preserved Ejection FractionChina
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of Sao PauloCompletedDiabetes Mellitus, Type 2 | Coronary Heart Disease | Arrythmia, CardiacBrazil
-
Boehringer IngelheimEli Lilly and CompanyActive, not recruiting
-
Vanderbilt University Medical CenterCompletedObesity | Pre-diabetesUnited States
-
Stanford UniversityCompletedLiver Cirrhosis | Cirrhosis | Ascites | Ascites Hepatic | Sodium-Glucose Transporter 2 InhibitorsUnited States
-
Zhijun SunEnrolling by invitationHeart Failure | Heart Failure With Preserved Ejection FractionChina
-
University Hospital, Basel, SwitzerlandCompletedHyponatremia | SIAD - Syndrome of Inappropriate AntidiuresisSwitzerland
-
Kobe UniversityBoehringer IngelheimActive, not recruitingInsulin Resistance - Type A | Insulin Resistance - Type B | Lipoatrophic Diabetes Mellitus | Insulin Resistance SyndromeJapan
-
Rajaie Cardiovascular Medical and Research CenterTehran Heart CenterRecruitingCABG | Post-operative Atrial FibrillationIran, Islamic Republic of
-
Washington D.C. Veterans Affairs Medical CenterBoehringer IngelheimRecruitingChronic Kidney DiseasesUnited States
-
Yale UniversityRecruiting
-
Sadat City UniversityRecruitingUlcerative ColitisEgypt
-
Shahid Beheshti University of Medical SciencesRecruitingKidney Transplant; ComplicationsIran, Islamic Republic of
-
University Hospital, Basel, SwitzerlandCentre Hospitalier Universitaire Vaudois; Luzerner KantonsspitalRecruitingLiver Failure | Hyponatremia | Kidney Failure | SIADHSwitzerland
-
University Hospital Inselspital, BerneCompletedDumping Syndrome | Hypoglycemia, ReactiveSwitzerland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, Italy, Poland, Russian Federation, Spain, Greece, Serbia, Thailand, Brazil, Hungary, Argentina
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited Kingdom
-
Amsterdam UMC, location VUmcCompleted
-
Juntendo UniversityBoehringer IngelheimRecruiting
-
Jacob MollerRigshospitalet, Denmark; University Hospital Bispebjerg and Frederiksberg; Hillerod... and other collaboratorsRecruitingHeart Failure | ObesityDenmark
-
University Hospital Inselspital, BerneBoehringer Ingelheim; University of BernCompleted
-
Ain Shams UniversityCompletedPharmacokinetics | PharmacogenomicEgypt
-
National Institute on Aging (NIA)CompletedPhysiological Effects of Drugs | Hypoglycemic Agents | Empaglifozin | Sodium-Glucose Transporter 2 InhibitorsUnited States
-
Mario Negri Institute for Pharmacological ResearchBoehringer IngelheimWithdrawnObesity | Non-diabetic Chronic Kidney Disease
-
Yaounde Central HospitalCompleted